文献速递胸部肿瘤

肺癌预后中的肥胖悖论:演变的生物学见解与临床意义

Obesity Paradox in Lung Cancer Prognosis: Evolving Biological Insights and Clinical Implications.
PubMed 文献 · J Thorac Oncol · 2017-07-27

肺癌生存率仍低,肥胖合并症带来新挑战。超重或肥胖患者生存获益的观察引出了肥胖悖论,即肥胖与肺癌死亡率呈意外负相关,其机制尚不明确。本文审视肥胖保护效应的潜在生物学机制,并强调需明确该关系的临床意义以更新干预策略。

要点

  • 超重或肥胖的肺癌患者中观察到生存获益,呈现肥胖悖论。
  • 肥胖表型异质性及与肺癌进展的生物学关联可能解释部分悖论。
  • 需设计良好的临床研究探究肥胖相关分子的因果作用。

核心结论

  • 肥胖与肺癌死亡率之间的意外负相关(肥胖悖论)仍知之甚少,需明确其临床意义以更新肺癌合并肥胖患者的干预策略。

研究设计与样本

  • 本文为综述,审视肥胖在肺癌中保护效应的潜在生物学机制。

主要发现

  • 尽管手术和化疗有进展,肺癌生存率仍低。
  • 超重或肥胖患者中观察到生存获益,形成肥胖悖论。
  • 肥胖表型异质性及与肺癌进展的生物学关联可能部分解释该悖论。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The survival rate of lung cancer remains low despite the progress of surgery and chemotherapy. With the increasing comorbidity of obesity in patients with lung cancer, new challenges are emerging in the management of this patient population. A key issue of interest is the prognostic effect of obesity on surgical and chemotherapeutic outcomes in patients with lung cancer, which is fueled by the growing observation of survival benefits in overweight or obese patients. This unexpected inverse relationship between obesity and lung cancer mortality, called the obesity paradox, remains poorly understood. The evolving insights into the heterogeneity of obesity phenotypes and associated biological connections with lung cancer progression in recent years may help explain some of the seemingly paradoxical relationship, and well-designed clinical studies looking at the causal role of obesity-associated molecules are expected. Here, we examine potential biological mechanisms behind the protective effects of obesity in lung cancer. We highlight the need to clarify the clinical implications of this relationship toward an updated intervention strategy in the clinical care of patients with lung cancer and obesity.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Zhang X, Liu Y, Shao H, et al. Obesity Paradox in Lung Cancer Prognosis: Evolving Biological Insights and Clinical Implications. J Thorac Oncol. 2017. PMID: 28757418. doi:10.1016/j.jtho.2017.07.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。